1. NCAA March Madness is a significant financial event with major revenue from media rights, sponsorships, and ticket sales, impacting sports betting and consumer promotions. 2. CoreWeave, backed by Nvidia, plans an IPO with shares ranging from $47 to $55, reporting significant revenue growth but also a net loss in 2024. 3. Sanofi acquires Dren Bio's immunology drug for up to $1.9B, targeting autoimmune indications and expanding its portfolio with a promising Phase 1 trial candidate.